Fenton Mary Kay

CIK 0001378589

Chief Financial OfficerDirector

Filings

Latest Feb 23, 2026

Issuers covered

Showing

9 of 9

Page 1

Track record

1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	1	100%	+5.9%	+5.9%	+5.9%	+5.9%
90 days	1	0%	-2.4%	-2.4%	-2.4%	-2.4%
180 days	-	-	-	-	-	-
365 days	-	-	-	-	-	-

Companies where Fenton Mary Kay has filed

Ticker	Issuer	Filings	Last filed
CGEM	Cullinan Oncology, Inc.	5	Feb 23, 2026
TRML	Tourmaline Bio, Inc.	3	Jul 6, 2023
ONCR	Oncorus, Inc.	1	Jun 24, 2022

9 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 23, 2026	CGEMCullinan Oncology, Inc.	SSale	4,398	$13.62	$59,901
Feb 19, 2026	CGEMCullinan Oncology, Inc.	AGrant	68,750	$0.00	$0
Jan 5, 2026	CGEMCullinan Oncology, Inc.	AGrant	27	$6.49	$175
Feb 21, 2025	CGEMCullinan Oncology, Inc.	AGrant	60,000	$0.00	$0
Apr 30, 2024	CGEMCullinan Oncology, Inc.	Holdings only	-	-	-
Jul 6, 2023	TRMLTourmaline Bio, Inc.	FTax	12,946	$3.08	$39,874
Feb 3, 2023	TRMLTourmaline Bio, Inc.	Holdings only	-	-	-
Jun 24, 2022	ONCROncorus, Inc.	Holdings only	-	-	-
Feb 2, 2022	TRMLTourmaline Bio, Inc.	AGrant	1,000	$13.00	$13,000

Showing 1-9 of 9

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.